CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 209 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02566980
NCT02566980N/ACompleted
CompareCT.gov

The Role of Kynurenine Pathway Metabolites in Perinatal Depression and Suicidality

Michigan State University·observational·Posted Oct 2, 2015·Updated Jun 28, 2018

In Brief

An observational study for Depression and Suicide and 2 related conditions. Completed, enrolled 209 participants across 3 sites.

Detailed Summary

The goal of the study is to define and measure biological processes that contribute to the underlying pathophysiologic process of peri-partum depression to be used for identifying those at risk for developing it. This knowledge may also generate novel drug targets for peripartum depression that may be applicable to other types of depression.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDepression and Suicide, Mood Disorders, Other Perinatal Conditions
CountriesUnited States
CollaboratorsPine Rest Christian Mental Health Services, Van Andel Research Institute, Corewell Health West, National Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 2, 2015
Enrollment StartOct 23, 2014
Primary CompletionFeb 28, 2017
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.8 years ago